A Preliminary Study on the Potential Protective Role of the Antioxidative Stress Markers of Cognitive Impairment: Glutathione and Glutathione Reductase

키워드

참고문헌 (38)

1. Eratne D, "Alzheimer’s disease : Clinical update on epidemiology, pathophysiology and diagnosis", Australas Psychiatry, 26, pp.347~357 (2018)
2. Mandal PK, "Cognitive improvement with glutathione supplement in Alzheimer’s disease : A way forward", J Alzheimers Dis, 68, pp.531~535 (2019)
3. Nestor PJ, "Advances in the early detection of Alzheimer’s disease", Nat Med, 10(Suppl), pp.S34~S41 (2004)
4. Butterfield DA, "Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease", Nat Rev Neurosci, 20, pp.148~160 (2019)
5. Martínez de Toda I, "Altered redox state in whole blood cells from patients with mild cognitive impairment and Alzheimer’s disease", J Alzheimers Dis, 71, pp.153~163 (2019)
6. Nunomura A, "Oxidative damage is the earliest event in Alzheimer disease", J Neuropathol Exp Neurol, 60, pp.759~767 (2001)
7. Cheignon C, "Oxidative stress and the amyloid beta peptide in Alzheimer’s disease", Redox Biol, 14, pp.450~464 (2018)
8. Goschorska M, "Influence of acetylcholinesterase inhibitors used in Alzheimer’s disease treatment on the activity of antioxidant enzymes and the concentration of glutathione in THP-1 macrophages under fluoride-induced oxidative stress", Int J Environ Res Public Health, 16, pp.10~ (2018)
9. Chen JJ, "Altered central and blood glutathione in Alzheimer’s disease and mild cognitive impairment : A metaanalysis", Alzheimers Res Ther, 14, pp.23~ (2022)
10. Charisis S, "Plasma GSH levels and Alzheimer’s disease. A prospective approach. : Results from the HELIAD study", Free Radic Biol Med, 162, pp.274~282 (2021)
11. Rani P, "Study on analysis of peripheral biomarkers for Alzheimer’s disease diagnosis", Front Neurol, 8, pp.328~ (2017)
12. Yuan L, "Dietary pattern and antioxidants in plasma and erythrocyte in patients with mild cognitive impairment from China", Nutrition, 32, pp.193~198 (2016)
13. Aybek H, "Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer’s disease in Denizli, Turkey", Clin Biochem, 40, pp.172~176 (2007)
14. Ji Won Han, "Overview of the Korean Longitudinal Study on Cognitive Aging and Dementia", PSYCHIATRY INVESTIGATION, 15(8), pp.767~774 (2018), 대한신경정신의학회[DOI]
15. Lee JH, "Development of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet(CERAD-K) : Clinical and neuropsychological assessment batteries", J Gerontol B Psychol Sci Soc Sci, 57, pp.P47~P53 (2002)
16. Bell CC, "DSM-IV : Diagnostic and statistical manual of mental disorders", JAMA, 272, pp.828~829 (1994)
17. Byeon G, "Dual Sensory impairment and cognitive impairment in the Korean longitudinal elderly cohort", Neurology, 96, pp.e2284~e2295 (2021)
18. Hughes CP, "A new clinical scale for the staging of dementia", Br J Psychiatry, 140, pp.566~572 (1982)
19. McKhann G, "Clinical diagnosis of Alzheimer’s disease : Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease", Neurology, 34, pp.939~944 (1984)
20. Román GC, "Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop", Neurology, 43, pp.250~260 (1993)
21. Petersen RC, "Mild cognitive impairment as a diagnostic entity", J Intern Med, 256, pp.183~194 (2004)
22. Miller MD, "Rating chronic medical illness burden in geropsychiatric practice and research : application of the Cumulative Illness Rating Scale", Psychiatry Res, 41, pp.237~248 (1992)
23. Tae Hui Kim, "Korean Version of Mini Mental Status Examination for Dementia Screening and Its Short Form", PSYCHIATRY INVESTIGATION, 7(2), pp.102~108 (2010), 대한신경정신의학회
24. Lee DY, "A normative study of the CERAD neuropsychological assessment battery in the Korean elderly", J Int Neuropsychol Soc, 10, pp.72~81 (2004)
25. Seo EH, "Total scores of the CERAD neuropsychological assessment battery : Validation for mild cognitive impairment and dementia patients with diverse etiologies", Am J Geriatr Psychiatry, 18, pp.801~809 (2010)
26. "Glutathione ELISA Kit (OKEH02622)"[URL]
27. "ELISA Kit for Glutathione Reductase (GR)"[URL]
28. Cenini G, "Oxidative stress in neurodegenerative diseases : From a mitochondrial point of view", Oxid Med Cell Longev, 2019, pp.2105607~ (2019)
29. Bermejo P, "Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer’s disease from Mild Cognitive Impairment", Free Radic Res, 42, pp.162~170 (2008)
30. Torres LL, "Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer’s disease", J Alzheimers Dis, 26, pp.59~68 (2011)
31. Pradier C, "The mini mental state examination at the time of Alzheimer’s disease and related disorders diagnosis, according to age, education, gender and place of residence : A cross-sectional study among the French National Alzheimer database", PLoS One, 9, pp.e103630~ (2014)
32. Liu H, "Gender differences in glutathione metabolism in Alzheimer’s disease", J Neurosci Res, 79, pp.861~867 (2005)
33. Calamia M, "Scoring higher the second time around : Meta-analyses of practice effects in neuropsychological assessment", Clin Neuropsychol, 26, pp.543~570 (2012)
34. Woltjer RL, "Role of glutathione in intracellular amyloid-alpha precursor protein", carboxy-terminal fragment aggregation and associated cytotoxicity, 2005, pp.93, 1047~1056
35. Saharan S, "The emerging role of glutathione in Alzheimer’s disease", J Alzheimers Dis, 40, pp.519~529 (2014)
36. Jack CR Jr, "Cerebral amyloid PET imaging in Alzheimer’s disease", Acta Neuropathol, 126, pp.643~657 (2013)
37. Pocernich CB, "Elevation of glutathione as a therapeutic strategy in Alzheimer disease", Biochim Biophys Acta, 1822, pp.625~630 (2012)
38. Shim YS, "Clinicopathologic study of Alzheimer’s disease : Alzheimer mimics", J Alzheimers Dis, 35, pp.799~811 (2013)

관련 논문AI추천